Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Omnicell Inc (OMCL)

Omnicell Inc (OMCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,856,561
  • Shares Outstanding, K 44,877
  • Annual Sales, $ 1,185 M
  • Annual Income, $ 2,050 K
  • EBIT $ 5 M
  • EBITDA $ 94 M
  • 60-Month Beta 0.78
  • Price/Sales 1.52
  • Price/Cash Flow 14.52
  • Price/Book 1.46

Options Overview Details

View History
  • Implied Volatility 56.94% (+5.82%)
  • Historical Volatility 66.13%
  • IV Percentile 51%
  • IV Rank 38.11%
  • IV High 89.58% on 04/08/25
  • IV Low 36.84% on 09/02/25
  • Expected Move (DTE 22) 3.22 (7.68%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 31
  • Put/Call OI Ratio 0.92
  • Today's Open Interest 980
  • Open Int (30-Day) 1,314
  • Expected Range 38.71 to 45.15

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.12
  • Number of Estimates 3
  • High Estimate 0.16
  • Low Estimate 0.09
  • Prior Year 0.08
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.38 +18.51%
on 02/09/26
50.70 -17.30%
on 01/28/26
-8.39 (-16.67%)
since 01/26/26
3-Month
35.38 +18.51%
on 02/09/26
55.00 -23.76%
on 01/13/26
+5.27 (+14.38%)
since 11/26/25
52-Week
22.66 +85.04%
on 05/06/25
55.00 -23.76%
on 01/13/26
+2.20 (+5.54%)
since 02/26/25

Most Recent Stories

More News
3 Cash-Producing Stocks We Find Risky

3 Cash-Producing Stocks We Find Risky

MGM : 37.62 (+5.79%)
HOLX : 75.23 (-0.15%)
OMCL : 41.93 (+1.35%)
Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know

Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know

GH : 97.97 (+2.83%)
OMCL : 41.93 (+1.35%)
PACB : 1.7800 (+9.20%)
ALGN : 189.20 (+0.61%)
QDEL : 22.70 (-2.70%)
The Top 5 Analyst Questions From Omnicell’s Q4 Earnings Call

The Top 5 Analyst Questions From Omnicell’s Q4 Earnings Call

OMCL : 41.93 (+1.35%)
OMCL Q4 Deep Dive: Product Launches, Tariff Headwinds, and Margin Pressures Shape Outlook

OMCL Q4 Deep Dive: Product Launches, Tariff Headwinds, and Margin Pressures Shape Outlook

OMCL : 41.93 (+1.35%)
Why Omnicell (OMCL) Shares Are Plunging Today

Why Omnicell (OMCL) Shares Are Plunging Today

OMCL : 41.93 (+1.35%)
Omnicell: Q4 Earnings Snapshot

Omnicell: Q4 Earnings Snapshot

OMCL : 41.93 (+1.35%)
Omnicell’s (NASDAQ:OMCL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations

Omnicell’s (NASDAQ:OMCL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations

OMCL : 41.93 (+1.35%)
Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results

Omnicell delivers solid fourth quarter 2025 financial results A nnounces major step toward autonomous medication management with the launch of its next generation...

OMCL : 41.93 (+1.35%)
Omnicell Earnings: What To Look For From OMCL

Omnicell Earnings: What To Look For From OMCL

OMCL : 41.93 (+1.35%)
Healthcare Technology for Providers Stocks Q3 Highlights: Omnicell (NASDAQ:OMCL)

Healthcare Technology for Providers Stocks Q3 Highlights: Omnicell (NASDAQ:OMCL)

OMCL : 41.93 (+1.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution,...

See More

Key Turning Points

3rd Resistance Point 44.50
2nd Resistance Point 43.55
1st Resistance Point 42.74
Last Price 41.93
1st Support Level 40.98
2nd Support Level 40.03
3rd Support Level 39.22

See More

52-Week High 55.00
Fibonacci 61.8% 42.65
Last Price 41.93
Fibonacci 50% 38.83
Fibonacci 38.2% 35.01
52-Week Low 22.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar